QQQ   293.48 (+1.66%)
AAPL   143.11 (+4.01%)
MSFT   260.65 (+3.20%)
FB   196.23 (+1.39%)
GOOGL   2,229.76 (+2.37%)
AMZN   2,151.14 (-0.03%)
TSLA   674.90 (+1.66%)
NVDA   168.98 (+1.22%)
BABA   87.23 (+0.51%)
NIO   16.00 (-2.68%)
AMD   95.07 (+1.68%)
CGC   5.19 (-5.98%)
MU   69.59 (+1.00%)
T   20.74 (+1.67%)
GE   75.46 (+0.28%)
F   12.83 (+2.64%)
DIS   105.83 (+3.33%)
AMC   11.58 (-3.74%)
PFE   52.88 (+0.78%)
PYPL   81.18 (+0.79%)
NFLX   187.44 (+0.58%)
QQQ   293.48 (+1.66%)
AAPL   143.11 (+4.01%)
MSFT   260.65 (+3.20%)
FB   196.23 (+1.39%)
GOOGL   2,229.76 (+2.37%)
AMZN   2,151.14 (-0.03%)
TSLA   674.90 (+1.66%)
NVDA   168.98 (+1.22%)
BABA   87.23 (+0.51%)
NIO   16.00 (-2.68%)
AMD   95.07 (+1.68%)
CGC   5.19 (-5.98%)
MU   69.59 (+1.00%)
T   20.74 (+1.67%)
GE   75.46 (+0.28%)
F   12.83 (+2.64%)
DIS   105.83 (+3.33%)
AMC   11.58 (-3.74%)
PFE   52.88 (+0.78%)
PYPL   81.18 (+0.79%)
NFLX   187.44 (+0.58%)
QQQ   293.48 (+1.66%)
AAPL   143.11 (+4.01%)
MSFT   260.65 (+3.20%)
FB   196.23 (+1.39%)
GOOGL   2,229.76 (+2.37%)
AMZN   2,151.14 (-0.03%)
TSLA   674.90 (+1.66%)
NVDA   168.98 (+1.22%)
BABA   87.23 (+0.51%)
NIO   16.00 (-2.68%)
AMD   95.07 (+1.68%)
CGC   5.19 (-5.98%)
MU   69.59 (+1.00%)
T   20.74 (+1.67%)
GE   75.46 (+0.28%)
F   12.83 (+2.64%)
DIS   105.83 (+3.33%)
AMC   11.58 (-3.74%)
PFE   52.88 (+0.78%)
PYPL   81.18 (+0.79%)
NFLX   187.44 (+0.58%)
QQQ   293.48 (+1.66%)
AAPL   143.11 (+4.01%)
MSFT   260.65 (+3.20%)
FB   196.23 (+1.39%)
GOOGL   2,229.76 (+2.37%)
AMZN   2,151.14 (-0.03%)
TSLA   674.90 (+1.66%)
NVDA   168.98 (+1.22%)
BABA   87.23 (+0.51%)
NIO   16.00 (-2.68%)
AMD   95.07 (+1.68%)
CGC   5.19 (-5.98%)
MU   69.59 (+1.00%)
T   20.74 (+1.67%)
GE   75.46 (+0.28%)
F   12.83 (+2.64%)
DIS   105.83 (+3.33%)
AMC   11.58 (-3.74%)
PFE   52.88 (+0.78%)
PYPL   81.18 (+0.79%)
NFLX   187.44 (+0.58%)
NASDAQ:CSII

Cardiovascular Systems (CSII) Stock Forecast, Price & News

$16.07
+0.46 (+2.95%)
(As of 05/23/2022 12:00 AM ET)
Add
Compare
Today's Range
$15.50
$16.30
50-Day Range
$14.42
$23.34
52-Week Range
$14.12
$44.57
Volume
377,182 shs
Average Volume
398,355 shs
Market Capitalization
$655.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.91
30 days | 90 days | 365 days | Advanced Chart
Receive CSII News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardiovascular Systems and its competitors with MarketBeat's FREE daily newsletter.

Cardiovascular Systems logo

About Cardiovascular Systems

Cardiovascular Systems, Inc., a medical device company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products, which are catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. The company has a partnership with Chansu Vascular Technologies, LLC to develop peripheral and coronary everolimus drug-coated balloons. The company was formerly known as Shturman Cardiology Systems, Inc. and changed its name to Cardiovascular Systems, Inc. in January 2003. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:CSII
CUSIP
14161910
Employees
780
Year Founded
1989

Sales & Book Value

Annual Sales
$258.97 million
Book Value
$6.22 per share

Profitability

Net Income
$-13.42 million
Pretax Margin
-13.16%

Debt

Price-To-Earnings

Miscellaneous

Free Float
39,561,000
Market Cap
$655.41 million
Optionable
Optionable

Company Calendar

Last Earnings
5/04/2022
Today
5/23/2022
Fiscal Year End
6/30/2022
Next Earnings (Estimated)
8/03/2022

Social Links


MarketRank

Overall MarketRank

2.33 out of 5 stars

Medical Sector

251st out of 1,423 stocks

Surgical & Medical Instruments Industry

30th out of 138 stocks

Analyst Opinion: 3.1Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.6 5 -4 -3 -2 -1 -













Cardiovascular Systems (NASDAQ:CSII) Frequently Asked Questions

Is Cardiovascular Systems a buy right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cardiovascular Systems in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Cardiovascular Systems stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CSII, but not buy additional shares or sell existing shares.
View analyst ratings for Cardiovascular Systems
or view top-rated stocks.

When is Cardiovascular Systems' next earnings date?

Cardiovascular Systems is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for Cardiovascular Systems
.

How were Cardiovascular Systems' earnings last quarter?

Cardiovascular Systems, Inc. (NASDAQ:CSII) issued its earnings results on Wednesday, May, 4th. The medical device company reported ($0.25) EPS for the quarter, beating the consensus estimate of ($0.28) by $0.03. The medical device company earned $56.22 million during the quarter, compared to the consensus estimate of $57.38 million. Cardiovascular Systems had a negative trailing twelve-month return on equity of 12.43% and a negative net margin of 13.29%. Cardiovascular Systems's quarterly revenue was down 11.1% compared to the same quarter last year. During the same quarter last year, the business earned ($0.15) EPS.
View Cardiovascular Systems' earnings history
.

What guidance has Cardiovascular Systems issued on next quarter's earnings?

Cardiovascular Systems updated its FY 2022 earnings guidance on Monday, May, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $235.00 million-$240.00 million, compared to the consensus revenue estimate of $237.88 million.

What price target have analysts set for CSII?

7 equities research analysts have issued 12-month price objectives for Cardiovascular Systems' stock. Their forecasts range from $20.00 to $49.00. On average, they anticipate Cardiovascular Systems' stock price to reach $39.40 in the next twelve months. This suggests a possible upside of 145.2% from the stock's current price.
View analysts' price targets for Cardiovascular Systems
or view top-rated stocks among Wall Street analysts.

Who are Cardiovascular Systems' key executives?
Cardiovascular Systems' management team includes the following people:
  • Mr. Scott Raymond Ward B.Sc., M.S., MS, Chairman, Pres & CEO (Age 62, Pay $1.46M)
  • Mr. Jeffrey S. Points, Chief Financial Officer (Age 45, Pay $682.69k) (LinkedIn Profile)
  • Ms. Rhonda J. Robb, Chief Operating Officer (Age 54, Pay $954.83k) (LinkedIn Profile)
  • Mr. Alexander Rosenstein, Gen. Counsel & Corp. Sec. (Age 50, Pay $614.96k)
  • Mr. John M. Hastings, Exec. VP of Operations & Technology (Age 42)
  • Mr. John E. Nielsen, VP of Investor Relations & Corp. Communications
  • Ms. Sandra M. Sedo, Chief Compliance Officer (Age 58)
  • Mr. David S. Whitescarver, VP of Corp. Devel. & Intellectual Property (Age 64)
  • Mr. Stephen J. Rempe, Chief HR Officer (Age 49)
  • Dr. Jeffrey W. Chambers M.D., Chief Medical Officer
What is Scott Ward's approval rating as Cardiovascular Systems' CEO?

12 employees have rated Cardiovascular Systems CEO Scott Ward on Glassdoor.com. Scott Ward has an approval rating of 81% among Cardiovascular Systems' employees.

What other stocks do shareholders of Cardiovascular Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include Gilead Sciences (GILD), AbbVie (ABBV), Advanced Micro Devices (AMD), Medtronic (MDT), Pfizer (PFE), Xcel Energy (XEL), ACADIA Pharmaceuticals (ACAD), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK) and Procter & Gamble (PG).

What is Cardiovascular Systems' stock symbol?

Cardiovascular Systems trades on the NASDAQ under the ticker symbol "CSII."

Who are Cardiovascular Systems' major shareholders?

Cardiovascular Systems' stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (17.38%), Champlain Investment Partners LLC (8.55%), Vanguard Group Inc. (6.35%), State Street Corp (4.22%), Renaissance Technologies LLC (2.09%) and Neuberger Berman Group LLC (1.98%). Company insiders that own Cardiovascular Systems stock include Alexander Rosenstein, Erik Paulsen, Jeffrey S Points, Martha Goldberg Aronson, Rhonda J Robb, Sandra Sedo and Scott R Ward.
View institutional ownership trends for Cardiovascular Systems
.

Which major investors are selling Cardiovascular Systems stock?

CSII stock was sold by a variety of institutional investors in the last quarter, including Invesco Ltd., Engineers Gate Manager LP, JPMorgan Chase & Co., Vanguard Group Inc., Assenagon Asset Management S.A., Exchange Traded Concepts LLC, Walleye Capital LLC, and Renaissance Technologies LLC.
View insider buying and selling activity for Cardiovascular Systems
or view top insider-selling stocks.

Which major investors are buying Cardiovascular Systems stock?

CSII stock was acquired by a variety of institutional investors in the last quarter, including Federated Hermes Inc., Royal Bank of Canada, BlackRock Inc., Neuberger Berman Group LLC, GSA Capital Partners LLP, White Pine Capital LLC, Envestnet Asset Management Inc., and M&T Bank Corp. Company insiders that have bought Cardiovascular Systems stock in the last two years include Erik Paulsen, Jeffrey S Points, Martha Goldberg Aronson, Rhonda J Robb, and Scott R Ward.
View insider buying and selling activity for Cardiovascular Systems
or or view top insider-buying stocks.

How do I buy shares of Cardiovascular Systems?

Shares of CSII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cardiovascular Systems' stock price today?

One share of CSII stock can currently be purchased for approximately $16.07.

How much money does Cardiovascular Systems make?

Cardiovascular Systems has a market capitalization of $655.41 million and generates $258.97 million in revenue each year. The medical device company earns $-13.42 million in net income (profit) each year or ($0.840010) on an earnings per share basis.

How many employees does Cardiovascular Systems have?

Cardiovascular Systems employs 780 workers across the globe.

When was Cardiovascular Systems founded?

Cardiovascular Systems was founded in 1989.

What is Cardiovascular Systems' official website?

The official website for Cardiovascular Systems is www.csi360.com.

How can I contact Cardiovascular Systems?

Cardiovascular Systems' mailing address is 1225 OLD HWY 8 NW, ST. PAUL MN, 55112. The medical device company can be reached via phone at (651) 259-1600, via email at [email protected], or via fax at 612-677-3355.

This page was last updated on 5/23/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.